MERIDIAN BIOSCIENCE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-11-20: Reporting owner Rice John McCune Jr.; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-11-05: Reporting owner McIlwraith John; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-10-04: Reporting owner Ellingwood Dwight E; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-09-20: Reporting owner Williams Felicia; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-11-20 | Rice John McCune Jr. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 10,000 owned after | $13.55 exercise price | 2018-11-21 | |
| 2018-11-05 | McIlwraith John Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 10,000 owned after | $12.80 exercise price | 2018-11-07 | |
| 2018-10-04 | Ellingwood Dwight E Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 11,000 owned after | $12.80 exercise price | 2018-10-04 | |
| 2018-09-20 | Williams Felicia Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $15.15 exercise price | 2018-09-24 | |
| 2018-06-04 | Rasmussen Eric S. Officer (EVP, Bus. Development/Strategy) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $15.05 exercise price | 2018-06-06 | |
| 2018-04-25 holding as of filing | WELTZIEN LOURDES Officer (Executive VP, Life Science) | 3 | Stock Options (Right to Buy) Derivative · Direct | Holding | $29.55 exercise price | 2018-04-25 | ||
| 2018-04-25 holding as of filing | WELTZIEN LOURDES Officer (Executive VP, Life Science) | 3 | Stock Options (Right to Buy) Derivative · Direct | Holding | $19.66 exercise price | 2018-04-25 | ||
| 2018-04-25 holding as of filing | WELTZIEN LOURDES Officer (Executive VP, Life Science) | 3 | Stock Options (Right to Buy) Derivative · Direct | Holding | $14.65 exercise price | 2018-04-25 | ||
| 2018-04-24 | WELTZIEN LOURDES Officer (EVP, Life Science) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $14.30 exercise price | 2018-04-26 | |
| 2018-01-25 | Sazdanoff Catherine Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $16.20 exercise price | 2018-01-26 | |
| 2018-01-25 | Rice John McCune Jr. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $16.20 exercise price | 2018-01-26 | |
| 2018-01-25 | PHILLIPS DAVID Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $16.20 exercise price | 2018-01-26 | |
| 2018-01-25 | McIlwraith John Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $16.20 exercise price | 2018-01-26 | |
| 2018-01-25 | Ellingwood Dwight E Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $16.20 exercise price | 2018-01-26 | |
| 2018-01-25 | Anderson James M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $16.20 exercise price | 2018-01-26 |